D.L. Olivera

561 total citations
12 papers, 472 citations indexed

About

D.L. Olivera is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, D.L. Olivera has authored 12 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in D.L. Olivera's work include Cytokine Signaling Pathways and Interactions (4 papers), Bone health and treatments (3 papers) and Bone Metabolism and Diseases (3 papers). D.L. Olivera is often cited by papers focused on Cytokine Signaling Pathways and Interactions (4 papers), Bone health and treatments (3 papers) and Bone Metabolism and Diseases (3 papers). D.L. Olivera collaborates with scholars based in United States and United Kingdom. D.L. Olivera's co-authors include Maxine Gowen, Mark Nuttall, Amanda J. Patton, Daniel P. Nadeau, A M Badger, Klaus Esser, Ian E. James, James E. Talmadge, Robert A. Dodds and Nazeeh Hanna and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Bone and Mineral Research and Bone.

In The Last Decade

D.L. Olivera

12 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.L. Olivera United States	8	248	114	105	104	104	12	472
P. Lencel France	8	223 0.9×	82 0.7×	109 1.0×	92 0.9×	92 0.9×	8	558
Olfa Ghali France	7	209 0.8×	72 0.6×	66 0.6×	93 0.9×	67 0.6×	7	440
Adeline Ng Canada	8	264 1.1×	90 0.8×	77 0.7×	80 0.8×	86 0.8×	10	554
Sindhu T. Mohanty Australia	10	179 0.7×	132 1.2×	43 0.4×	87 0.8×	135 1.3×	15	412
Kristen R. Georgiou Australia	14	223 0.9×	213 1.9×	60 0.6×	65 0.6×	118 1.1×	18	601
Guangsi Shen China	13	342 1.4×	87 0.8×	54 0.5×	88 0.8×	139 1.3×	22	665
Bari Gabbitas United States	15	389 1.6×	144 1.3×	70 0.7×	28 0.3×	91 0.9×	18	640
Atsuhiro Fujie Japan	11	279 1.1×	124 1.1×	67 0.6×	26 0.3×	117 1.1×	16	495
M. V. Alvarez-Arroyo Spain	9	265 1.1×	184 1.6×	35 0.3×	25 0.2×	77 0.7×	13	469
M. Couch United Kingdom	6	113 0.5×	91 0.8×	105 1.0×	39 0.4×	57 0.5×	9	346

Countries citing papers authored by D.L. Olivera

Since Specialization

Citations

This map shows the geographic impact of D.L. Olivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.L. Olivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.L. Olivera more than expected).

Fields of papers citing papers by D.L. Olivera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.L. Olivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.L. Olivera. The network helps show where D.L. Olivera may publish in the future.

Co-authorship network of co-authors of D.L. Olivera

This figure shows the co-authorship network connecting the top 25 collaborators of D.L. Olivera. A scholar is included among the top collaborators of D.L. Olivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.L. Olivera. D.L. Olivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Yao, Wei, Jing Jia, Weiwei Dai, et al.. (2014). Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass. Osteoporosis International. 25(6). 1735–1750. 18 indexed citations

Nuttall, Mark, Amanda J. Patton, D.L. Olivera, Daniel P. Nadeau, & Maxine Gowen. (1998). Human Trabecular Bone Cells Are Able to Express Both Osteoblastic and Adipocytic Phenotype: Implications for Osteopenic Disorders. Journal of Bone and Mineral Research. 13(3). 371–382. 294 indexed citations

James, Ian E., Robert A. Dodds, D.L. Olivera, Mark Nuttall, & Maxine Gowen. (1996). Human osteoclastoma-derived stromal cells: Correlation of the ability to form mineralized nodules in vitro with formation of bone in vivo. Journal of Bone and Mineral Research. 11(10). 1453–1460. 50 indexed citations

James, Ian E., et al.. (1995). Formation of bone by human osteoclastoma-derived stromal cells in the severe combined immunodeficient (SCID) mouse model is preceded by mouse osteoclast differentiation. Bone. 17(6). 578–578. 2 indexed citations

Badger, A M, D.L. Olivera, & Klaus Esser. (1994). Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock.. PubMed. 44(4). 188–95. 35 indexed citations

Olivera, D.L., et al.. (1993). Effects of pyridinyl imidazole compounds on murine TNF-α production. Inflammation Research. 39(S1). C55–C57. 9 indexed citations

Olivera, D.L., et al.. (1993). Divergent Effects of Rapamycin on Mouse and Rat Cells Following Mitogenic Stimulation. Clinical Immunology and Immunopathology. 68(3). 357–362. 5 indexed citations

King, Andrew, D.L. Olivera, James E. Talmadge, & Alison M. Badger. (1991). Induction of non-specific suppressor cells and myeloregulatory effects of an immunomodulatory azaspirane, SK&F 105685. International Journal of Immunopharmacology. 13(1). 91–100. 9 indexed citations

Kaplan, Johanne, et al.. (1991). Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.. PubMed. 36(4). 49–58. 1 indexed citations

10.

Albrightson-Winslow, C R, B Brickson, Andrew King, et al.. (1990). Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis.. Journal of Pharmacology and Experimental Therapeutics. 255(1). 382–387. 4 indexed citations

11.

Albrightson-Winslow, C R, B Brickson, Anne L. King, et al.. (1990). Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis.. PubMed. 255(1). 382–7. 16 indexed citations

12.

Badger, A M, D.L. Olivera, James E. Talmadge, & Nazeeh Hanna. (1989). Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action.. PubMed. 27(1). 51–61. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact